Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Telmisartan 80 mg vs Micardis 80 mg in healthy Thai participants
TCTR20260208008Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of telmisartan (2 arms), sponsored by Bio-innova. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
telmisartan
Beyond the preview
Go deeper on TCTR20260208008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260208008.